Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Cited by (251)

Items 101–200 of 251

1. Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease
   Tokuda, Takahiko, Salem, Sultan A., Allsop, David, Mizuno, Toshiki, Nakagawa, Masanori, Qureshi, Mohamed M., Locascio, Joseph J., Schlossmacher, Michael G., El-Agnaf, Omar M.A. · 2006 · Biochemical and Biophysical Research Communications
2. Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein
   Willingham, Stephen, Outeiro, Tiago Fleming, DeVit, Michael J., Lindquist, Susan L., Muchowski, Paul J. · 2003 · Science
3. Degradation of α-Synuclein by Proteasome
   Bennett, M. Catherine, Bishop, John F., Leng, Yan, Chock, P. Boon, Chase, Thomas N., Mouradian, M. Maral · 1999 · Journal of Biological Chemistry
4. MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration
   Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., Standaert, D. G. · 2013 · Journal of Neuroscience
5. α-synuclein in the pathophysiology of Alzheimer’s disease
   Twohig, Daniel, Nielsen, Henrietta M. · 2019 · Molecular Neurodegeneration
6. β-Synuclein Inhibits α-Synuclein Aggregation
   Hashimoto, Makoto, Rockenstein, Edward, Mante, Michael, Mallory, Margaret, Masliah, Eliezer · 2001 · Neuron
7. Exploring Braak’s hypothesis of Parkinson’s disease
   Rietdijk, Carmen D., Perez-Pardo, Paula, Garssen, Johan, van Wezel, Richard J. A., Kraneveld, Aletta D. · 2017 · Frontiers in Neurology
8. Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
   Mollenhauer, Brit, Cullen, Valerie, Kahn, Ilana, Krastins, Bryan, Outeiro, Tiago F., Pepivani, Imelda, Ng, Juliana, Schulz-Schaeffer, Walter, Kretzschmar, Hans A., McLean, Pamela J. et al. · 2008 · Experimental Neurology
9. α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356
   Jensen, Poul Henning, Hager, Henrik, Nielsen, Morten S., Højrup, Peter, Gliemann, Jørgen, Jakes, Ross · 1999 · Journal of Biological Chemistry
10. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
    Monzio Compagnoni, Giacomo, Di Fonzo, Alessio, Corti, Stefania, Comi, Giacomo P., Bresolin, Nereo, Masliah, Eliezer · 2020 · Molecular Neurobiology
11. Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
    Altamura, Sandro, Muckenthaler, Martina U. · 2009 · Journal of Alzheimer's Disease
12. Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease
    Gao, Hui-Ming, Zhang, Feng, Zhou, Hui, Kam, Wayneho, Wilson, Belinda, Hong, Jau-Shyong · 2011 · Environmental Health Perspectives
13. Brain iron pathways and their relevance to Parkinson's disease
    Berg, D, Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., Becker, G. · 2001 · Journal of Neurochemistry
14. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection
    Chung, Chee Yeun, Seo, Hyemyung, Sonntag, Kai Christian, Brooks, Andrew, Lin, Ling, Isacson, Ole · 2005 · Human Molecular Genetics
15. Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
    Borghi, Roberta, Marchese, Roberta, Negro, Alessandro, Marinelli, Lucio, Forloni, Gianluigi, Zaccheo, Damiano, Abbruzzese, Giovanni, Tabaton, Massimo · 2000 · Neuroscience Letters
16. Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
    Koprich, James B, Reske-Nielsen, Casper, Mithal, Prabhakar, Isacson, Ole · 2008 · Journal of Neuroinflammation
17. The role of Nrf2 signaling in counteracting neurodegenerative diseases
    Dinkova‐Kostova, Albena T., Kostov, Rumen V., Kazantsev, Aleksey G. · 2018 · The FEBS Journal
18. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
    Cebrián, Carolina, Zucca, Fabio A., Mauri, Pierluigi, Steinbeck, Julius A., Studer, Lorenz, Scherzer, Clemens R., Kanter, Ellen, Budhu, Sadna, Mandelbaum, Jonathan, Vonsattel, Jean P. et al. · 2014 · Nature Communications
19. Proposed neuropathological criteria for the <i>post mortem</i> diagnosis of multiple system atrophy
    Trojanowski, J. Q., Revesz, T., the Neuropathology Working Group on MSA · 2007 · Neuropathology and Applied Neurobiology
20. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
    Wakabayashi, K., Hayashi, Shintaro, Kakita, Akiyoshi, Yamada, Mitsunori, Toyoshima, Yasuko, Yoshimoto, Makoto, Takahashi, Hitoshi · 1998 · Acta Neuropathologica
21. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
    Janezic, Stephanie, Threlfell, Sarah, Dodson, Paul D., Dowie, Megan J., Taylor, Tonya N., Potgieter, Dawid, Parkkinen, Laura, Senior, Steven L., Anwar, Sabina, Ryan, Brent et al. · 2013 · Proceedings of the National Academy of Sciences
22. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease
    Bai, Bing, Hales, Chadwick M., Chen, Ping-Chung, Gozal, Yair, Dammer, Eric B., Fritz, Jason J., Wang, Xusheng, Xia, Qiangwei, Duong, Duc M., Street, Craig et al. · 2013 · Proceedings of the National Academy of Sciences
23. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases
    Yan, Zhaoqi, Gibson, Sara A., Buckley, Jessica A., Qin, Hongwei, Benveniste, Etty N. · 2018 · Clinical Immunology
24. Local gene knockdown in the brain using viral-mediated RNA interference
    Hommel, Jonathan D, Sears, Robert M, Georgescu, Dan, Simmons, Diana L, DiLeone, Ralph J · 2003 · Nature Medicine
25. Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy
    Tanik, Selcuk A., Schultheiss, Christine E., Volpicelli-Daley, Laura A., Brunden, Kurt R., Lee, Virginia M.Y. · 2013 · Journal of Biological Chemistry
26. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
    Dettmer, Ulf, Newman, Andrew J., Soldner, Frank, Luth, Eric S., Kim, Nora C., von Saucken, Victoria E., Sanderson, John B., Jaenisch, Rudolf, Bartels, Tim, Selkoe, Dennis · 2015 · Nature Communications
27. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons
    Wood-Kaczmar, Alison, Gandhi, Sonia, Yao, Zhi, Abramov, Andrey S. Y., Miljan, Erik A., Keen, Gregory, Stanyer, Lee, Hargreaves, Iain, Klupsch, Kristina, Deas, Emma et al. · 2008 · PLoS ONE
28. Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
    Daniele, Stefano G., Béraud, Dawn, Davenport, Connor, Cheng, Kui, Yin, Hang, Maguire-Zeiss, Kathleen A. · 2015 · Science Signaling
29. Alpha‐Synuclein as a Biomarker for Parkinson's Disease
    Atik, Anzari, Stewart, Tessandra, Zhang, Jing · 2016 · Brain Pathology
30. Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases
    Alexander, Adanna G., Marfil, Vanessa, Li, Chris · 2014 · Frontiers in Genetics
31. The identity and function of microglia in neurodegeneration
    Song, Wilbur M., Colonna, Marco · 2018 · Nature Immunology
32. Oxidative and nitrosative stress in Parkinson's disease
    Tsang, Anthony H.K., Chung, Kenny K.K. · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
33. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement
    Schipper, Hyman M., Song, Wei, Zukor, Hillel, Hascalovici, Jacob R., Zeligman, David · 2009 · Journal of Neurochemistry
34. Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise
    Micheli, Laura, Ceccarelli, Manuela, D’Andrea, Giorgio, Tirone, Felice · 2018 · Brain Research Bulletin
35. Behavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice
    Richfield, Eric K., Thiruchelvam, Mona J., Cory-Slechta, Deborah A., Wuertzer, Charles, Gainetdinov, Raul R., Caron, Marc G., Di Monte, Donato A., Federoff, Howard J. · 2002 · Experimental Neurology
36. Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
    Gan, Li, Johnson, Jeffrey A. · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
37. Intraneuronal dopamine-quinone synthesis: a review
    Sulzer, David, Zecca, Luigi · 1999 · Neurotoxicity Research
38. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
    Dzamko, Nicolas, Gysbers, Amanda, Perera, Gayathri, Bahar, Anita, Shankar, Amrita, Gao, Jianqun, Fu, YuHong, Halliday, Glenda M. · 2017 · Acta Neuropathologica
39. Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter
    Matsuoka, Yasuji, Vila, Miquel, Lincoln, Sarah, McCormack, Alison, Picciano, Melanie, LaFrancois, John, Yu, Xin, Dickson, Dennis, Langston, William J., McGowan, Eileen et al. · 2001 · Neurobiology of Disease
40. Individual dopaminergic neurons show raised iron levels in Parkinson disease
    Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A., Elstner, M., Morris, C. M. · 2007 · Neurology
41. In Situ and in Vitro Study of Colocalization and Segregation of α-Synuclein, Ubiquitin, and Lipids in Lewy Bodies
    Gai, W.P., Yuan, H.X., Li, X.Q., Power, J.T.H., Blumbergs, P.C., Jensen, P.H. · 2000 · Experimental Neurology
42. Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo
    Angot, Elodie, Steiner, Jennifer A., Lema Tomé, Carla M., Ekström, Peter, Mattsson, Bengt, Björklund, Anders, Brundin, Patrik · 2012 · PLoS ONE
43. Tyrosine Hydroxylase and Parkinson’s Disease
    Haavik, Jan, Toska, Karen · 1998 · Molecular Neurobiology
44. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel, Stanley H., Beers, David R., Henkel, Jenny S. · 2010 · Trends in Immunology
45. Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
    Sanchez-Guajardo, Vanesa, Febbraro, Fabia, Kirik, Deniz, Romero-Ramos, Marina · 2010 · PLoS ONE
46. Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy
    Shults, Clifford W., Rockenstein, Edward, Crews, Leslie, Adame, Anthony, Mante, Michael, Larrea, Gabriel, Hashimoto, Makoto, Song, David, Iwatsubo, Takeshi, Tsuboi, Kyoko et al. · 2005 · The Journal of Neuroscience
47. Molecular pathogenesis of Parkinson's disease
    Gandhi, Sonia, Wood, Nicholas W. · 2005 · Human Molecular Genetics
48. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
    Uchihara, Toshiki, Giasson, Benoit I. · 2016 · Acta Neuropathologica
49. Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
    Allen Reish, Heather E., Standaert, David G. · 2015 · Journal of Parkinson’s Disease
50. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
    Overk, Cassia R., Masliah, Eliezer · 2014 · Biochemical Pharmacology
51. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
    Arima, K., Uéda, Kenji, Sunohara, Nobuhiko, Arakawa, Kenji, Hirai, Shigeo, Nakamura, Minako, Tonozuka-Uehara, Haruko, Kawai, Mitsuru · 1998 · Acta Neuropathologica
52. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and neurodegeneration in a model of Parkinson disease
    Harms, Ashley S., Thome, Aaron D., Yan, Zhaoqi, Schonhoff, Aubrey M., Williams, Gregory P., Li, Xinru, Liu, Yudong, Qin, Hongwei, Benveniste, Etty N., Standaert, David G. · 2018 · Experimental Neurology
53. α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
    Klegeris, Andis, Pelech, Steven, Giasson, Benoit I., Maguire, John, Zhang, Hong, McGeer, Edith G., McGeer, Patrick L. · 2008 · Neurobiology of Aging
54. Deep learning for freezing of gait detection in Parkinson’s disease patients in their homes using a waist-worn inertial measurement unit
    Camps, Julià, Samà, Albert, Martín, Mario, Rodríguez-Martín, Daniel, Pérez-López, Carlos, Moreno Arostegui, Joan M., Cabestany, Joan, Català, Andreu, Alcaine, Sheila, Mestre, Berta et al. · 2018 · Knowledge-Based Systems
55. Microglia in Parkinson's disease
    Ho, Margaret S. · 2019 · Advances in Experimental Medicine and Biology
56. Mitochondrial Medicine for Aging and Neurodegenerative Diseases
    Reddy, P. Hemachandra · 2008 · NeuroMolecular Medicine
57. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
    Li, Yunna, Xia, Yun, Yin, Sijia, Wan, Fang, Hu, Junjie, Kou, Liang, Sun, Yadi, Wu, Jiawei, Zhou, Qiulu, Huang, Jinsha et al. · 2021 · Frontiers in Immunology
58. Inflammation is genetically implicated in Parkinson’s disease
    Dzamko, N., Geczy, C.L, Halliday, G.M · 2015 · Neuroscience
59. In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells
    Dettmer, Ulf, Newman, Andrew J., Luth, Eric S., Bartels, Tim, Selkoe, Dennis · 2013 · Journal of Biological Chemistry
60. Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body Disease
    Mandal, Pravat K., Pettegrew, Jay W., Masliah, Eliezer, Hamilton, Ronald L., Mandal, Ratna · 2006 · Neurochemical Research
61. Alpha synuclein is transported into and out of the brain by the blood-brain barrier
    Sui, Yu-Ting, Bullock, Kristin M., Erickson, Michelle A., Zhang, Jing, Banks, W.A. · 2014 · Peptides
62. CHIP: a quality-control E3 ligase collaborating with molecular chaperones
    Murata, Shigeo, Chiba, Tomoki, Tanaka, Keiji · 2003 · The International Journal of Biochemistry &amp; Cell Biology
63. Dopamine Oxidation and Autophagy
    Muñoz, Patricia, Huenchuguala, Sandro, Paris, Irmgard, Segura-Aguilar, Juan · 2012 · Parkinson's Disease
64. Cerebrospinal fluid biomarkers in Parkinson disease
    Parnetti, Lucilla, Castrioto, Anna, Chiasserini, Davide, Persichetti, Emanuele, Tambasco, Nicola, El-Agnaf, Omar, Calabresi, Paolo · 2013 · Nature Reviews Neurology
65. Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease
    McNaught, Kevin St. P., Olanow, C. Warren · 2003 · Annals of Neurology
66. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
    Manfredsson, Fredric P., Luk, Kelvin C., Benskey, Matthew J., Gezer, Aysegul, Garcia, Joanna, Kuhn, Nathan C., Sandoval, Ivette M., Patterson, Joseph R., O'Mara, Alana, Yonkers, Reid et al. · 2018 · Neurobiology of Disease
67. The Role of LRRK2 in Neurodegeneration of Parkinson Disease
    Rui, Qin, Ni, Haibo, Li, Di, Gao, Rong, Chen, Gang · 2018 · Current Neuropharmacology
68. α‐Synuclein produces a long‐lasting increase in neurotransmitter release
    Liu, Shumin, Ninan, Ipe, Antonova, Irina, Battaglia, Fortunato, Trinchese, Fabrizio, Narasanna, Archana, Kolodilov, Nikolai, Dauer, William, Hawkins, Robert D, Arancio, Ottavio · 2004 · The EMBO Journal
69. Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity
    Bido, Simone, Muggeo, Sharon, Massimino, Luca, Marzi, Matteo Jacopo, Giannelli, Serena Gea, Melacini, Elena, Nannoni, Melania, Gambarè, Diana, Bellini, Edoardo, Ordazzo, Gabriele et al. · 2021 · Nature Communications
70. Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
    Troncoso-Escudero, Paulina, Parra, Alejandra, Nassif, Melissa, Vidal, Rene L. · 2018 · Frontiers in Neurology
71. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration
    Oliveras-Salvá, Marusela, Van der Perren, Anke, Casadei, Nicolas, Stroobants, Stijn, Nuber, Silke, D’Hooge, Rudi, Van den Haute, Chris, Baekelandt, Veerle · 2013 · Molecular Neurodegeneration
72. Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes
    Rannikko, Emmy H., Weber, Stephanie S., Kahle, Philipp J. · 2015 · BMC Neuroscience
73. Prion-like spread of protein aggregates in neurodegeneration
    Polymenidou, Magdalini, Cleveland, Don W. · 2012 · Journal of Experimental Medicine
74. Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene
    Hattori, Nobutaka, Matsumine, Hiroto, Asakawa, Shuichi, Kitada, Tohru, Yoshino, Hiroyo, Elibol, Blüent, Brookes, Anthony J., Yamamura, Yasuhiro, Kobayashi, Tomonori, Wang, Mei et al. · 1998 · Biochemical and Biophysical Research Communications
75. The role of mitochondria in inherited neurodegenerative diseases
    Kwong, Jennifer Q., Beal, M. Flint, Manfredi, Giovanni · 2006 · Journal of Neurochemistry
76. Premotor Parkinson’s disease: Concepts and definitions
    Siderowf, Andrew, Lang, Anthony E. · 2012 · Movement Disorders
77. Lewy Body Pathology in Alzheimer's Disease
    Kotzbauer, Paul T., Tojanowski, John Q., Lee, Virginia M. V. · 2001 · Journal of Molecular Neuroscience
78. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
    Liu, Guoxiang, Yu, Jia, Ding, Jinhui, Xie, Chengsong, Sun, Lixin, Rudenko, Iakov, Zheng, Wang, Sastry, Namratha, Luo, Jing, Rudow, Gay et al. · 2014 · Journal of Clinical Investigation
79. Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides
    Reglodi, Dora, Renaud, Justine, Tamas, Andrea, Tizabi, Yousef, Socías, Sergio B., Del-Bel, Elaine, Raisman-Vozari, Rita · 2017 · Progress in Neurobiology
80. Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy
    Fussi, Natascha, Höllerhage, Matthias, Chakroun, Tasnim, Nykänen, Niko-Petteri, Rösler, Thomas W., Koeglsperger, Thomas, Wurst, Wolfgang, Behrends, Christian, Höglinger, Günter U. · 2018 · Cell Death &amp; Disease
81. Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation
    Zhang, Qiu-Shuang, Heng, Yang, Yuan, Yu-He, Chen, Nai-Hong · 2017 · Toxicology Letters
82. Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein
    Yu, Wai Haung, Dorado, Beatriz, Figueroa, Helen Yvette, Wang, Lili, Planel, Emmanuel, Cookson, Mark R., Clark, Lorraine N., Duff, Karen E. · 2009 · The American Journal of Pathology
83. Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies
    Schildknecht, Stefan, Gerding, Hanne R., Karreman, Christiaan, Drescher, Malte, Lashuel, Hilal A., Outeiro, Tiago F., Di Monte, Donato A., Leist, Marcel · 2013 · Journal of Neurochemistry
84. Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease
    Tóth, Gergely, Gardai, Shyra J., Zago, Wagner, Bertoncini, Carlos W., Cremades, Nunilo, Roy, Susan L., Tambe, Mitali A., Rochet, Jean-Christophe, Galvagnion, Celine, Skibinski, Gaia et al. · 2014 · PLoS ONE
85. Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
    Kouli, Antonina, Horne, C.B., Williams-Gray, C.H. · 2019 · Brain Behavior and Immunity
86. A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
    Gallardo, Gilbert, Schlüter, Oliver M, Südhof, Thomas C · 2008 · Nature Neuroscience
87. Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
    Su, Xiaomin, Federoff, Howard J., Maguire-Zeiss, Kathleen A. · 2009 · Neurotoxicity Research
88. Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy
    Ahmed, Ishrat, Liang, Yideng, Schools, Sabitha, Dawson, Valina L., Dawson, Ted M., Savitt, Joseph M. · 2012 · The Journal of Neuroscience
89. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation
    Simon, D.K., Pulst, S.M., Sutton, J.P., Browne, S.E., Beal, M.F., Johns, D.R. · 1999 · Neurology
90. Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
    Sacino, Amanda N., Brooks, Mieu, McKinney, Alex B., Thomas, Michael A., Shaw, Gerry, Golde, Todd E., Giasson, Benoit I. · 2014 · The Journal of Neuroscience
91. Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders
    Alirezaei, Zahra, Pourhanifeh, Mohammad Hossein, Borran, Sarina, Nejati, Majid, Mirzaei, Hamed, Hamblin, Michael R. · 2020 · Molecular Neurobiology
92. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
    Davis, Albert A., Leyns, Cheryl E.G., Holtzman, David M. · 2018 · Annual Review of Cell and Developmental Biology
93. A New Treatment Strategy for Parkinson's Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway
    Kim, Dong Seok, Choi, Ho-Il, Wang, Yun, Luo, Yu, Hoffer, Barry J., Greig, Nigel H. · 2017 · Cell Transplantation
94. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
    Brás, Inês C., Outeiro, Tiago F. · 2021 · Cells
95. Could a loss of α‐synuclein function put dopaminergic neurons at risk?
    Perez, Ruth G., Hastings, Teresa G. · 2004 · Journal of Neurochemistry
96. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
    Salehi, Ahmad, Delcroix, Jean-Dominique, Mobley, William C. · 2003 · Trends in Neurosciences
97. N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders
    Healy-Stoffel, Michelle, Levant, Beth · 2018 · CNS &amp; Neurological Disorders - Drug Targets
98. Neurotheranostics as Personalized Medicines
    Kevadiya, Bhavesh D., Ottemann, Brendan M., Thomas, Midhun Ben, Mukadam, Insiya, Nigam, Saumya, McMillan, JoEllyn, Gorantla, Santhi, Bronich, Tatiana K., Edagwa, Benson, Gendelman, Howard E. · 2019 · Advanced Drug Delivery Reviews
99. Development, wiring and function of dopamine neuron subtypes
    Garritsen, Oxana, van Battum, Eljo Y., Grossouw, Laurens M., Pasterkamp, R. Jeroen · 2023 · Nature reviews. Neuroscience
100. Does cellular iron dysregulation play a causative role in Parkinson’s disease?
     Kaur, Deepinder, Andersen, Julie · 2004 · Ageing Research Reviews